Skip to main content
Filing year 2024

ALS THERAPY DEVELOPMENT FOUNDATION INC

Watertown, Massachusetts·EIN 04-3462719·NTEE H80 · Medical Research·501(c)(3)
Total revenue
$13.4M
Total assets
$23.1M
Total expenses
$12.9M
Reported officers
23
Mission

OUR MISSION IS TO IDENTIFY VIABLE TARGETS FOR THERAPY DEVELOPMENT AND EXPEDITIOUSLY MANAGE THE CREATION OF THOSE TREATMENTS THAT WILL ARREST THE SUFFERING OF TODAY'S ALS PATIENTS.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 6 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

CEO and CSO
75th to 90th percentilevs Medical Research peers in Massachusetts
$415k
$443k
Base
$387k
Bonus
Other
Benefits
$20k
VP of Research
Board Vice President
25th percentile to median
$209k
$223k
Base
$189k
Bonus
Other
Benefits
$12k
VP of Development
Board Vice President
25th percentile to median
$187k
$200k
Base
$173k
Bonus
Other
Benefits
$8k
Director, Cell Biology
Highest Compensated Employee
25th percentile to median
$185k
$198k
Base
$158k
Bonus
Other
Benefits
$20k
Director of Pharmacology
Highest Compensated Employee
25th percentile to median
$170k
$181k
Base
$156k
Bonus
Other
Benefits
$8k
Senior Director of Marketing & Communications
Director (Operational)
Median to 75th percentile
$156k
$166k
Base
$135k
Bonus
Other
Benefits
$15k

Teal figures restate each filed amount in 2026 dollars.

Estimated with Boston-Cambridge-Newton, MA-NH metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 17 unpaid individuals.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at ALS THERAPY DEVELOPMENT FOUNDATION INC equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
3%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Up 22%
from 2023

From $340k in 2023 to $415k in 2024.

$340k
2023
$415k
2024
In today's dollarsEst.
Up 18% in real terms$374k to $443k

Estimated with Boston-Cambridge-Newton, MA-NH metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Chief Executive Officer pay rose 22% from 2023 to 2024, while revenue rose 16%.

$340k in 2023 to $415k in 2024.
  • Board Vice President pay rose 7% from 2023 to 2024.
  • Highest Compensated Employee pay rose 8% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

FAQ

Common questions about ALS THERAPY DEVELOPMENT FOUNDATION INC

What does the Chief Executive Officer of ALS THERAPY DEVELOPMENT FOUNDATION INC earn?

In 2024, the Chief Executive Officer of ALS THERAPY DEVELOPMENT FOUNDATION INC received $414,933 in total compensation. This pay is in the top quarter for Chief Executive Officer roles among Medical Research organizations in Massachusetts, though not the top 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at ALS THERAPY DEVELOPMENT FOUNDATION INC compare with similar nonprofits?

Compared with the same role at Medical Research organizations in Massachusetts, the 2024 pay of the Chief Executive Officer at ALS THERAPY DEVELOPMENT FOUNDATION INC falls between the 75th and 90th percentiles. In 2024, the highest total compensation at ALS THERAPY DEVELOPMENT FOUNDATION INC equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

What are ALS THERAPY DEVELOPMENT FOUNDATION INC's revenue and expenses?

In 2024, ALS THERAPY DEVELOPMENT FOUNDATION INC reported $13.4M in total revenue and $12.9M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.